The hypotriglycedemic action of ACTH was investigated in the hyperlipemic patients of various diseases. This effect was apparent within 30 min after intravenous injection of the hormone and lasted up to 96 hr when it was administered intramuscularly. ACTH had no effect on the serum cholesterol or phospholipid concentration. As possible causes of this effect of ACTH, fatty acids mobilization and lipoprotein lipase activation were excluded and hepatic involvement was suggested.
Synopsis
The hypotriglycedemic action of ACTH was investigated in the hyperlipemic patients of various diseases. This effect was apparent within 30 min after intravenous injection of the hormone and lasted up to 96 hr when it was administered intramuscularly. ACTH had no effect on the serum cholesterol or phospholipid concentration. As possible causes of this effect of ACTH, fatty acids mobilization and lipoprotein lipase activation were excluded and hepatic involvement was suggested. (Friedman et al., 1964; Friedman et al., 1967 (Dole, 1956 ).
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Results
Effect of ACTH on serum TG concentration Figure 1 shows the results of ACTH administration either intravenously or intramuscularly to a patient (Y. I.) of carbohydrate induced hyperlipemia. When administered intramuscularly in an amount of 1.0mg, ACTH decreased the serum TG concentration from 1208, 890mg/dl to 275, 80mg/dl in 24 hr and to 130, 125mg/dl in 48 hr, respectively. In another study, ACTH depressed the high TG concentration of 775mg/dl to 83mg/dl in 24 hr and remained to be less than 150mg/dl for no less than 96 hr. The effect of ACTH became apparent within 4 hr by this route of administration. When administered intravenously, 250 j g of ACTH lowered the serum TG concentration already in 30min by nearly 50%. It is not only in this patient that the hypotriglycedemic action of ACTH was observed, but in other hyperlipemic patients of various diseases responded in the same manner. In Table 1 is summarized the result in the patients who responded to the ACTH administration. Besides the patient described above (Y. I.), hyperlipemics of various diseases, namely acromegaly, essential hyperlipemia, diabetes or hypopituitarism, responded to ACTH. In Table 2 are listed those who did not respond to the ACTH administration. Most of the cases are clearly those whose fasting blood TG concentrations were low to begin with. However, 2 cases are included in the table who had high blood TG concentration and did not respond to ACTH. One of them was a patient of Cushing's syndrome associated with diabetes and the other was a diabetic. The blood TG concentration of either case fell within normal Table 1 . Change in serum TG concentration (mg/dl) after ACTH administration (Responders) 1mg of synthetic ACTH was injected intramascularly at 0 time. Figure 2 , his fasting TG concentration in blood was 300mg/dl prior to the administration of ACTH. Twenty-four hours after the administration, it decreased to 150mg/dl and remained to be lowered in another 24 hr thereafter. Again, no change Effect of ACTH on serum free fatty acid (FFA) concentration ACTH has been known to stimulate lipolysis in adipose tissue when added in vitro or administered in vivo in animals of various species. However, in men no apparent effect on plasma FFA has been observed in vivo. Figure 3 shows the effect of ACTH on the plasma FFA concentration in the patients who responded to ACTH with a decrease of blood TG concentration. No consistent effect on plasma FFA was observed.
Effect of ACTH on posthaparin lipoprotein lipase activity in blood
As shown in Table 5 , lipoprotein lipase activity did not change significantly in samples of 4, 8, 24 or 48 hr after the ACTH administration in one patient (Y. I.), who showed the cient to exhibit the effect. Secondly, our result shows that the effect of ACTH in lowering plasma TG concentration was so marked, which was not noted in their study. In one patient (Y. I.), the tremendous hypertriglycedemia of more than 1000mg/dl was decreased to a normal range within 24 hr on one occasion, and almost to a normal limit in 24 hr and to a subnormal range in 48 hr in another. In other patients, marked hyperlipemia was also amended almost completely in 24 hr. Thirdly, Friedman et al. failed to demonstrate the hypolipemic effect in Addisonian patients (Friedman et al., 1964) . In our patient of Addison's disease, the TG lowering effect was clearly demonstrated by ACTH. The reason for this discrepancy is not clear. However, in spite of their own result, they believed that ACTH itself was active, since a large amount of hydrocortisone did not replicate the effect of ACTH. Finally, the hypotriglycedemic effect of ACTH was apparent as early as 30 min after its intravenous administration. As for the duration of this effect of ACTH, it was apparent as long as 48 hr and on one occasion lowered plasma TG level remained normal up to 96 hr. Most of the study which Friedman et al. reported was up to 24 hr after the ACTH administration (Friedman et al., 1964) . They reported that the fasting and four-hour postprandial serum TG values returned to the control level 72 hr after the injection of ACTH (Friedman et al., 1967) . They studied the moderately hyperlipemic patients and we also observed a tendency to return toward their previous levels 48 hr after the administration of ACTH in those moderately hyperlipemic patients. The longer effective period we have observed in a patient of marked hyperlipemia may simply be because it takes more time to return to a markedly elevated initial level of plasma TG.
As possible cause(s) for this effect of ACTH, Friedman et al. excluded the participation of insulin which is known to be released by ACTH administration in some species of animals but not in men (Friedman et al., 1967) . Insulin pretreatment did not have any effect on pre-and postprandial hypertriglycedemia (Friedman et al., 1967) . Serum FFA concentration and postheparin lipoprotein lipase activity was not affected by the ad-ministration of ACTH in one patient studied. Thus ACTH seems to have nothing to do with FFA mobilization or TG clearing by lipoprotein lipase. The mechanism of this hypotriglycedemic action still remains to be elucidated. However, judging from its rapid action and prevention of postprandial hyperlipemia, it should be related to the removal of lipid from the blood stream by the liver, probably without the aid of a lipoprotein lipase activity. Judging from the relatively long lived effect, the effect should also be related to the synthesis and release of TG into the circulation from the liver.
As was mentioned in the results, there were some patients who did not respond to ACTH administration despite their elevated plasma TG level. The reason for this discrepancy is not clear at present. Also, further studies are certainly awaited as for the effect of long term administration on plasma lipid concentrations as well as on lipid content in peripheral tissues, especially in liver.
